United-Guardian (UG) Stock Price, News & Analysis

Company Overview

United-Guardian, Inc., headquartered in Hauppauge, New York, develops and supplies specialty ingredients and finished products for the personal care, cosmetic and esthetic markets. Its Specialty Ingredients segment offers antimicrobial preservatives, conditioning polymers, emulsifiers, UV filters and other functional actives that are incorporated into lotions, creams, shampoos and professional esthetic formulations.

The company’s Finished Products segment markets a range of skin and hair care items under the Guardian brand, providing private-label and contract manufacturing services to spas, salons and dermatology clinics. United-Guardian leverages its in-house research and development laboratories and regulatory expertise to support product formulation, testing and compliance with industry standards.

United-Guardian maintains manufacturing operations at its New York facility and distributes its products through a network of domestic and international partners. The company emphasizes quality control and innovation, collaborating with formulators and beauty professionals to address emerging trends in skin health, anti-aging and sun protection.

Key Stats

• Today's Range: $7.10 to $7.62
• 50-Day Range: $7.00 to $8.20
• 52-Week Range: $5.58 to $8.77
• Volume: 5,551 shs
• Average Volume: 9,427 shs
• Market Capitalization: $33.37 million
• P/E Ratio: 13.46
• Dividend Yield: 8.25%
• Price Target: N/A
• Consensus Rating: Hold

United-Guardian Stock Analysis - MarketRank™

United-Guardian scored higher than 25% of companies evaluated by MarketBeat, and ranked 699th out of 917 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Hold

Consensus Rating

United-Guardian has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

United-Guardian has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of United-Guardian is 13.46, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 42.66.

Price to Earnings Ratio vs. Sector

The P/E ratio of United-Guardian is 13.46, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 210.65.

Price to Book Value per Share Ratio

United-Guardian has a P/B Ratio of 2.87. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.35% of the float of United-Guardian has been sold short.

Short Interest Ratio / Days to Cover

United-Guardian has a short interest ratio ("days to cover") of 1.29, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in United-Guardian has recently increased by 84.97%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

United-Guardian is a leading dividend payer. It pays a dividend yield of 8.40%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

United-Guardian has only been increasing its dividend for 1 years.

Dividend Coverage

The dividend payout ratio of United-Guardian is 111.11%. Payout ratios above 75% are not desirable because they may not be sustainable.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for United-Guardian this week, compared to 0 articles on an average week.

Company Ownership

• Score: 1.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, United-Guardian insiders have not sold or bought any company stock.

Percentage Held by Insiders

29.00% of the stock of United-Guardian is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

23.16% of the stock of United-Guardian is held by institutions.

Company Calendar

• Record date for 8/4 Dividend: 7/28/2026
• Ex-Dividend for 8/4 Dividend: 7/28/2026
• Dividend Payable: 8/04/2026
• Last Earnings: 8/07/2026
• Today: 8/25/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:UG
• CIK: 101295
• Web: www.u-g.com
• Phone: (631) 273-0900
• Fax: 631-273-0858
• Employees: 20
• Year Founded: 1942

Profitability

• EPS (Trailing Twelve Months): $0.54
• Trailing P/E Ratio: 13.46
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $2.11 million
• Net Margins: 22.01%
• Pretax Margin: 27.62%
• Return on Equity: 22.24%
• Return on Assets: 19.12%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 7.32
• Quick Ratio: 6.64

Sales & Book Value

• Annual Sales: $10.55 million
• Price / Sales: 3.16
• Cash Flow: $0.49 per share
• Price / Cash Flow: 14.81
• Book Value: $2.53 per share
• Price / Book: 2.87

Miscellaneous

• Outstanding Shares: 4,590,000
• Free Float: 3,262,000
• Market Cap: $33.37 million
• Optionable: Not Optionable
• Beta: 0.95